In a landmark decision that will transform lives, the NHS has approved a revolutionary 'artificial pancreas' system for people with Type 1 diabetes after a decade-long battle by campaigners.
The National Institute for Health and Care Excellence (NICE) has given the green light to the hybrid closed-loop system, which automatically monitors blood glucose levels and delivers insulin as needed through a pump.
Life-changing technology
This cutting-edge technology represents the biggest advancement in diabetes treatment since the discovery of insulin in 1921. The system:
- Continuously monitors blood sugar levels
- Automatically adjusts insulin delivery
- Reduces dangerous hypoglycaemic episodes
- Improves long-term health outcomes
Long road to approval
Families of children with Type 1 diabetes and charities have campaigned tirelessly for NHS funding of the system, which has been available in other countries for years. The approval comes after:
- Initial NICE rejection due to cost concerns
- Successful pilot schemes showing benefits
- Growing evidence of long-term NHS savings
Diabetes UK estimates the technology could benefit over 100,000 people in England and Wales, particularly children and pregnant women who struggle most with blood sugar control.
What this means for patients
Experts say the system will:
- Reduce the constant burden of diabetes management
- Cut hospital admissions for dangerous blood sugar levels
- Potentially prevent devastating complications
- Improve quality of life and life expectancy
The NHS plans to roll out the treatment gradually, prioritizing those who would benefit most, with full implementation expected within five years.
